OpenAI Just Pulled the AMD Playbook Again — This Time at $56 Billion

Key Takeaways

• OpenAI granted warrants for ~10% of Cerebras at $0.01 per share
• Cerebras IPO values company at $56 billion, 96× trailing sales
• Revenue jumped 21‑fold to $510 million in 2025, 47% margin
• OpenAI loan and warrants tie its fortunes to Cerebras' performance
• Customer concentration exceeds 80% of revenue, raising execution risk

Pulse Analysis

OpenAI’s use of deep‑discount equity warrants is reshaping the economics of AI hardware procurement. After a similar arrangement with AMD that helped lift the chipmaker’s stock, OpenAI extended the playbook to Cerebras Systems, a wafer‑scale chip startup. By providing a $1 billion bridge loan secured with warrants to purchase more than 33 million shares at a penny each, OpenAI effectively secured a ten‑percent stake at a fraction of market value. This hidden equity component is buried in the S‑1 filing, yet it underpins the headline contract that propelled Cerebras to a $56 billion valuation, the largest U.S. tech IPO in nearly half a decade.

Cerebras’ business model targets the inference side of the AI boom, promising lower latency and power consumption than traditional GPU clusters. Its 2025 financials—$510 million in revenue and a 47% net margin—reflect rapid scaling, but the company’s risk profile is stark. Over 86% of its 2025 revenue came from two UAE‑linked customers, and the new OpenAI contract now represents the majority of its backlog. The warrants give OpenAI senior creditor rights, allowing it to demand repayment if delivery milestones slip, further amplifying execution risk. Meanwhile, competitors like NVIDIA, bolstered by a $20 billion acquisition of Groq, are intensifying the race for inference dominance, putting pressure on Cerebras to meet ambitious production targets on TSMC’s N5 node.

For investors, the Cerebras IPO forces a reassessment of headline contract announcements. The disclosed warrants mean that the market’s validation signal is partially offset by a hidden equity dilution that could materialize once OpenAI converts its options. If Cerebras can sustain its revenue growth and compress its price‑to‑sales multiple toward industry norms, the stock could justify its lofty valuation. Conversely, any delay or renegotiation by OpenAI could trigger warrant conversion, flooding the market with shares and eroding shareholder value. The broader implication is that future AI‑infrastructure deals may increasingly embed similar equity‑as‑discount mechanisms, compelling analysts to factor hidden dilution into valuation models and to watch OpenAI’s eventual public listing for a clearer picture of its dual role as both customer and shareholder.